Inicio>>Signaling Pathways>> Ubiquitination/ Proteasome>> Autophagy>>MRT67307 HCl

MRT67307 HCl

Catalog No.GC25650

MRT67307 is a potent and dual IKKε and TBK1 inhibitor with IC50 of 160 and 19 nM, respectively. MRT67307 potently inhibits ULK1 and ULK2 and blocks autophagy.

Products are for research use only. Not for human use. We do not sell to patients.

MRT67307 HCl Chemical Structure

Cas No.: 1781882-89-0

Tamaño Precio Disponibilidad Cantidad
5mg
52,00 $
Disponible
25mg
199,00 $
Disponible
100mg
457,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

MRT67307 is a potent and dual IKKε and TBK1 inhibitor with IC50 of 160 and 19 nM, respectively. MRT67307 potently inhibits ULK1 and ULK2 and blocks autophagy.

In macrophages, MRT67307 prevents the phosphorylation of IRF3 and the production of IFNβ. In wild-type MEFs, MRT67307 enhances the IL-1-stimulated phosphorylation of p105 at Ser933 and RelA at both Ser468 and Ser536, and also enhances IL-1-stimulated activation of NF-κB-dependent gene transcription. [1] MRT67307 increases IL-10 production and suppresses proinflammatory cytokine production via a cAMP response element-Binding protein (CREB)-regulated transcriptional coactivator (CRTC) 3 Dependent Mechanism. [2] In addition, MRT67307 inhibit ULK and block autophagy in MEF cells. [3]

[1] Clark K, et al. Biochem J. 2011, 434(1), 93-104. [2] Clark K, et al. Proc Natl Acad Sci U S A. 2012, 109(42), 16986-16991. [3] Petherick KJ, et al. J Biol Chem. 2015, 290(18), 11376-11383.

Reseñas

Review for MRT67307 HCl

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for MRT67307 HCl

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.